bendazac has been researched along with Extravascular Hemolysis in 1 studies
bendazac : A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bendazac is a drug previously reported to prevent protein denaturation produced by various agents, including free radicals." | 1.28 | Photosensitized haemolysis of human erythrocytes is reduced by bendazac. ( Ciancarelli-Tozzi, MG; Finazzi-Agro, A; Silvestrini, B, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciancarelli-Tozzi, MG | 1 |
| Silvestrini, B | 1 |
| Finazzi-Agro, A | 1 |
1 other study available for bendazac and Extravascular Hemolysis
| Article | Year |
|---|---|
Photosensitized haemolysis of human erythrocytes is reduced by bendazac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Hemolysis; Humans; In Vitro Techniques; Indazoles; Photolys | 1989 |